Latest reported quarter: Q2, ended Jun 2026
Quarter 2026/Q2
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $88.91M | $82.48M | $342.39M | $88.53M | $83.26M |
| Total Operating Revenue | $88.91M | $82.48M | $342.39M | $88.53M | $83.26M |
| Cost of Revenue | $19.19M | $19.45M | $71.06M | $18.90M | $17.14M |
| Gross Profit | $69.72M | $63.03M | $271.33M | $69.63M | $66.12M |
| Operating Expense | $71.60M | $73.87M | $272.18M | $71.27M | $63.75M |
| Selling and Admin Expenses | $54.67M | $57.81M | $207.18M | $55.77M | $49.09M |
| -Selling & Marketing Expense | $32.88M | $34.05M | $118.94M | $33.64M | $26.63M |
| -General & Admin Expense | $21.79M | $23.76M | $88.24M | $22.13M | $22.47M |
| Research & Development | $15.07M | $14.50M | $61.08M | $14.25M | $14.02M |
| Depreciation & Amortization & Depletion | $1.85M | $1.56M | $3.91M | $1.26M | $636,000.00 |
| -Depreciation & Amortization | $1.85M | $1.56M | $3.91M | $1.26M | $636,000.00 |
| Operating Profit | -$1.88M | -$10.83M | -$841,000.00 | -$1.64M | $2.37M |
| Net Non-Operating Interest Income (Expense) | $1.36M | $1.51M | $10.78M | $1.95M | $2.51M |
| Non-Operating Interest Income | $1.36M | – | – | – | $2.51M |
| Other Income (Expense) | -$11,000.00 | -$31,000.00 | -$93,000.00 | -$64,000.00 | $376,000.00 |
| Other Non-Operating Income (Expenses) | -$11,000.00 | -$31,000.00 | -$93,000.00 | -$64,000.00 | $376,000.00 |
| Pretax Profit | -$532,000.00 | -$9.35M | $9.85M | $244,000.00 | $5.25M |
| Tax | $697,000.00 | $969,000.00 | $6.27M | $1.25M | $3.72M |
| Net Profit | -$1.23M | -$10.32M | $3.58M | -$1.00M | $1.53M |
| Profit from Continuing Operations | -$1.23M | -$10.32M | $3.58M | -$1.00M | $1.53M |
| Net Income to Parent Company | -$1.23M | -$10.32M | $3.58M | -$1.00M | $1.53M |
| Net Income to Common Stockholders | -$1.23M | -$10.32M | $3.58M | -$1.00M | $1.53M |
| Basic EPS | -$0.05 | -$0.43 | $0.13 | -$0.04 | $0.05 |
| Diluted EPS | -$0.05 | -$0.43 | $0.12 | -$0.04 | $0.05 |
| Total Other Finance Costs | – | -$1.51M | -$10.78M | – | – |
| Special Income (Charges) | – | – | $0.00 | $0.00 | $0.00 |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $485.40M | $479.92M | $525.91M | $525.91M | $569.43M |
| Total Current Assets | $365.64M | $361.00M | $407.93M | $407.93M | $455.46M |
| Cash and Cash Equivalents & Short-Term Investments | $148.17M | $164.60M | $186.61M | $186.61M | $223.30M |
| -Cash and Cash Equivalents | $148.17M | $164.60M | $186.61M | $186.61M | $223.30M |
| Receivables | $203.39M | $183.05M | $208.71M | $208.71M | $212.82M |
| -Accounts Receivable | $203.39M | $183.05M | $208.71M | $208.71M | $212.82M |
| Other Current Assets | $14.07M | $13.35M | $12.60M | $12.60M | $19.28M |
| Total Non-Current Assets | $119.76M | $118.92M | $117.99M | $117.99M | $113.97M |
| Net PPE | $32.97M | $33.06M | $33.34M | $33.34M | $29.62M |
| -Gross PPE | $37.46M | $36.77M | $36.36M | $36.36M | $40.10M |
| -Accumulated Depreciation | -$4.49M | -$3.71M | -$3.03M | -$3.03M | -$10.48M |
| Investments and Advances | $4.53M | $4.53M | $4.53M | $4.53M | $4.53M |
| -Long Term Equity Investment | $4.53M | $4.53M | $4.53M | $4.53M | $4.53M |
| Goodwill and Other Intangible Assets | $27.96M | $26.48M | $24.19M | $24.19M | $22.36M |
| -Other Intangible Assets | $27.96M | $26.48M | $24.19M | $24.19M | $22.36M |
| Non-Current Deferred Assets | $53.49M | $53.89M | $54.85M | $54.85M | $56.50M |
| Other Non-Current Assets | $810,000.00 | $961,000.00 | $1.08M | $1.08M | $962,000.00 |
| Total Liabilities | $243.83M | $230.94M | $238.26M | $238.26M | $239.83M |
| Total Current Liabilities | $213.47M | $200.92M | $207.76M | $207.76M | $206.53M |
| Payables | $128.52M | $113.53M | $118.44M | $118.44M | $114.01M |
| -Accounts Payable | $7.31M | $7.24M | $10.84M | $10.84M | $15.31M |
| -Other Payable | $121.21M | $106.29M | $107.60M | $107.60M | $98.70M |
| Current Accrued Expenses | $4.20M | $8.21M | $7.81M | $7.81M | $5.83M |
| Current Deferred Liabilities | $2.60M | $2.70M | $2.94M | $2.94M | $4.69M |
| Other Current Liabilities | $63.00M | $64.94M | $66.77M | $66.77M | $71.10M |
| Total Non-Current Liabilities | $30.36M | $30.02M | $30.50M | $30.50M | $33.30M |
| Long Term Accounts Payable and Other Payables | $5.22M | $4.70M | $5.00M | $5.00M | $7.96M |
| Long Term Debt and Capital Lease Obligation | $25.13M | $25.32M | $25.50M | $25.50M | $25.34M |
| -Long Term Capital Lease Obligation | $25.13M | $25.32M | $25.50M | $25.50M | $25.34M |
| Total Equity | $241.57M | $248.98M | $287.65M | $287.65M | $329.61M |
| Stockholders' Equity | $241.57M | $248.98M | $287.65M | $287.65M | $329.61M |
| Capital Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -Common Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $725.95M | $708.89M | $692.10M | $692.10M | $677.51M |
| Retained Earnings | -$148.42M | -$147.19M | -$136.87M | -$136.87M | -$135.87M |
| Less: Treasury Stock | $335.95M | $312.72M | $267.58M | $267.58M | $212.03M |
| Restricted Cash | – | – | $0.00 | $0.00 | $58,000.00 |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | $13.26M | $30.37M | $95.27M | $27.81M | $21.75M |
| Net cash flow from continuing operations | $13.26M | $30.37M | $95.27M | $27.81M | $21.75M |
| Net Income from Continuing Operations | -$1.23M | -$10.32M | $3.58M | -$1.00M | $1.53M |
| Gain/Loss from Continuing Operations | $2.18M | $2.16M | $8.76M | $2.21M | $2.21M |
| Depreciation & Depletion & Amortization | $3.37M | $2.87M | $8.32M | $2.47M | $1.24M |
| Deferred Tax | $844,000.00 | $583,000.00 | $3.15M | – | – |
| Other Non-Cash Items | $41,000.00 | $41,000.00 | $182,000.00 | $54,000.00 | $43,000.00 |
| Change in Working Capital | -$5.97M | $19.53M | $24.67M | $9.94M | $4.64M |
| -Change in Receivables | -$20.69M | $24.87M | $10.24M | $4.09M | -$4.32M |
| -Change in Payables and Accrued Expense | $17.39M | -$2.55M | $12.72M | $9.57M | $2.83M |
| -Change in Other Current Assets | -$971,000.00 | -$236,000.00 | $3.44M | $5.17M | $20.55M |
| -Change in Other Current Liabilities | -$1.60M | -$2.31M | $293,000.00 | -$7.13M | -$13.96M |
| -Change In Other Working Capital | -$99,000.00 | -$234,000.00 | -$2.03M | -$1.76M | -$458,000.00 |
| Net cash flow from investing | -$5.20M | -$7.06M | -$34.30M | -$11.18M | -$11.16M |
| Net Cash Flow from Continuing Investing Activities | -$5.20M | -$7.06M | -$34.30M | -$11.18M | -$11.16M |
| Capital Expenditure | -$4.31M | -$4.02M | -$14.01M | -$3.65M | -$3.91M |
| Net PPE Purchase and Sale | -$890,000.00 | -$3.04M | -$20.29M | -$7.53M | -$7.25M |
| Financing Cash Flow | -$24.48M | -$45.33M | -$224.05M | -$53.37M | -$37.85M |
| Net Cash Flow from Continuing Financing Activities | -$24.48M | -$45.33M | -$224.05M | -$53.37M | -$37.85M |
| Net Common Stock Issuance | -$25.95M | -$44.83M | -$232.97M | -$54.79M | -$38.00M |
| Proceeds from Stock Option Exercised | $3.42M | $656,000.00 | $12.34M | $2.00M | $955,000.00 |
| Net Other Financing Charges | -$1.94M | -$1.15M | -$3.42M | -$577,000.00 | -$798,000.00 |
| Ending Cash Balance | $148.17M | $164.60M | $186.61M | $186.61M | $223.35M |
| Net Change in Cash | -$16.42M | -$22.02M | -$163.08M | -$36.74M | -$27.25M |
| Beginning Cash Balance | $164.60M | $186.61M | $349.69M | $223.35M | $250.61M |
| Free Cash Flow | $8.05M | $23.29M | $60.97M | $16.63M | $10.59M |
| Net Investment Purchase and Sale | – | – | $0.00 | – | – |
No comments yet — be the first to weigh in on IBTA.